Barclays’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $78.4M | Sell |
148,839
-38,876
| -21% | -$21.8M | 0.02% | 581 |
|
|
2026
Q1 | $105M | Sell |
187,715
-23,723
| -11% | -$15.2M | 0.03% | 474 |
|
|
2025
Q4 | $143M | Sell |
211,438
-25,232
| -11% | -$17.2M | 0.03% | 369 |
|
|
2025
Q3 | $151M | Sell |
236,670
-68,510
| -22% | -$41.6M | 0.03% | 373 |
|
|
2025
Q2 | $164M | Buy |
305,180
+25,509
| +9% | +$12.2M | 0.04% | 328 |
|
|
2025
Q1 | $117M | Buy |
279,671
+63,692
| +29% | +$27.7M | 0.03% | 374 |
|
|
2024
Q4 | $89.3M | Sell |
215,979
-236,377
| -52% | -$104M | 0.03% | 434 |
|
|
2024
Q3 | $229M | Buy |
452,356
+206,677
| +84% | +$100M | 0.06% | 231 |
|
|
2024
Q2 | $120M | Sell |
245,679
-79,182
| -24% | -$39.8M | 0.04% | 335 |
|
|
2024
Q1 | $175M | Buy |
324,861
+17,305
| +6% | +$9.46M | 0.06% | 258 |
|
|
2023
Q4 | $171M | Buy |
307,556
+59,080
| +24% | +$27.7M | 0.06% | 271 |
|
|
2023
Q3 | $109M | Buy |
248,476
+79,102
| +47% | +$39.4M | 0.07% | 290 |
|
|
2023
Q2 | $85.1M | Buy |
169,374
+82,862
| +96% | +$39.7M | 0.05% | 315 |
|
|
2023
Q1 | $43.3M | Sell |
86,512
-29,612
| -26% | -$14.2M | 0.02% | 523 |
|
|
2022
Q4 | $47.4M | Buy |
116,124
+25,527
| +28% | +$9.91M | 0.02% | 514 |
|
|
2022
Q3 | $29.5M | Sell |
90,597
-6,475
| -7% | -$2.38M | 0.03% | 476 |
|
|
2022
Q2 | $34M | Sell |
97,072
-37,041
| -28% | -$15.1M | 0.02% | 510 |
|
|
2022
Q1 | $73.4M | Sell |
134,113
-39,272
| -23% | -$20.7M | 0.06% | 305 |
|
|
2021
Q4 | $114M | Buy |
173,385
+12,176
| +8% | +$7.64M | 0.04% | 317 |
|
|
2021
Q3 | $100M | Buy |
161,209
+22,128
| +16% | +$14.9M | 0.05% | 322 |
|
|
2021
Q2 | $87.8M | Buy |
139,081
+3,606
| +3% | +$1.99M | 0.04% | 329 |
|
|
2021
Q1 | $66.3M | Buy |
135,475
+4,146
| +3% | +$2.08M | 0.04% | 369 |
|
|
2020
Q4 | $65.6M | Buy |
131,329
+23,238
| +21% | +$10.4M | 0.03% | 365 |
|
|
2020
Q3 | $42.5M | Sell |
108,091
-10,444
| -9% | -$3.86M | 0.03% | 445 |
|
|
2020
Q2 | $39.1M | Sell |
118,535
-26,431
| -18% | -$7.65M | 0.03% | 394 |
|
|
2020
Q1 | $35.1M | Sell |
144,966
-26,620
| -16% | -$6.95M | 0.03% | 423 |
|
|
2019
Q4 | $44.8M | Buy |
171,586
+14,771
| +9% | +$3.89M | 0.02% | 552 |
|
|
2019
Q3 | $42.6M | Buy |
156,815
+22,272
| +17% | +$6.2M | 0.03% | 523 |
|
|
2019
Q2 | $37M | Sell |
134,543
-11,276
| -8% | -$2.78M | 0.02% | 608 |
|
|
2019
Q1 | $32.6M | Buy |
145,819
+12,581
| +9% | +$2.6M | 0.02% | 604 |
|
|
2018
Q4 | $24.8M | Sell |
133,238
-37,413
| -22% | -$7.67M | 0.02% | 652 |
|
|
2018
Q3 | $42.6M | Buy |
170,651
+66,962
| +65% | +$16.3M | 0.03% | 483 |
|
|
2018
Q2 | $22.6M | Sell |
103,689
-26,898
| -21% | -$5.54M | 0.02% | 730 |
|
|
2018
Q1 | $25M | Buy |
130,587
+16,448
| +14% | +$3.04M | 0.02% | 737 |
|
|
2017
Q4 | $17.8M | Buy |
114,139
+48,773
| +75% | +$7.68M | 0.01% | 862 |
|
|
2017
Q3 | $10.2M | Sell |
65,366
-82,952
| -56% | -$13.1M | 0.01% | 1043 |
|
|
2017
Q2 | $23.9M | Buy |
148,318
+19,089
| +15% | +$3.1M | 0.03% | 522 |
|
|
2017
Q1 | $20M | Buy |
129,229
+77,507
| +150% | +$10.7M | 0.02% | 554 |
|
|
2016
Q4 | $6.07M | Sell |
51,722
-25,895
| -33% | -$2.96M | 0.01% | 1266 |
|
|
2016
Q3 | $8.75M | Sell |
77,617
-56,449
| -42% | -$5.95M | 0.01% | 942 |
|
|
2016
Q2 | $12.4M | Buy |
134,066
+41,605
| +45% | +$3.57M | 0.02% | 730 |
|
|
2016
Q1 | $7.21M | Buy |
92,461
+32,975
| +55% | +$2.37M | 0.01% | 936 |
|
|
2015
Q4 | $4.28M | Buy |
59,486
+44,859
| +307% | +$3.2M | 0.01% | 1436 |
|
|
2015
Q3 | $1.08M | Sell |
14,627
-24,908
| -63% | -$1.78M | ﹤0.01% | 2636 |
|
|
2015
Q2 | $2.53M | Sell |
39,535
-59,805
| -60% | -$4.14M | ﹤0.01% | 2037 |
|
|
2015
Q1 | $7.65M | Buy |
99,340
+91,472
| +1,163% | +$7.12M | 0.01% | 1249 |
|
|
2014
Q4 | $582K | Sell |
7,868
-144
| -2% | -$10.1K | ﹤0.01% | 3714 |
|
|
2014
Q3 | $469K | Sell |
8,012
-10,330
| -56% | -$653K | ﹤0.01% | 4007 |
|
|
2014
Q2 | $1.22M | Buy |
18,342
+14,266
| +350% | +$907K | ﹤0.01% | 3137 |
|
|
2014
Q1 | $247K | Sell |
4,076
-26,042
| -86% | -$1.55M | ﹤0.01% | 4589 |
|
|
2013
Q4 | $1.59M | Buy |
30,118
+12,404
| +70% | +$653K | ﹤0.01% | 2906 |
|
|
2013
Q3 | $876K | Buy |
17,714
+2,322
| +15% | +$112K | ﹤0.01% | 3501 |
|
|
2013
Q2 | $690K | Buy |
+15,392
| New | +$673K | ﹤0.01% | 3841 |
|
Other funds holding IDXX
Barclays's IDXX Position: Q2 2026 in Review
Barclays reduced its Idexx Laboratories (IDXX) stake by 21% in Q2 2026, selling an estimated $21.8M and leaving 148,839 shares worth $78.4M. The position accounts for 0.02% of the portfolio, ranked #581.
Barclays first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $229M in Q3 2024. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Barclays held 148,839 shares of Idexx Laboratories worth $78.4M as of Q2 2026.
- Barclays sold 38,876 Idexx Laboratories shares in Q2 2026, an estimated $21.8M.
- Idexx Laboratories made up 0.02% of Barclays's portfolio in Q2 2026, its #581 holding.
- Barclays first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
- Barclays's Idexx Laboratories position peaked at $229M in Q3 2024.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.